Johnson & Johnson Gets CERTIFIED and 4 Stocks Enjoying 52-Week Highs

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Johnson & Johnson’s (NYSE:JNJ) Janssen Diagnostics said that its web based electronic health record, or EHR, AVIGA has won a Complete EHR Ambulatory Certification. This designation makes the EHR capable of allowing providers to qualify for funding through the American Recovery and Reinvestment Act. The EHR software is compliant for 2011 to 2012 in accordance with the criteria adopted by the Secretary of Health and Human Services, and has been tested and certified under the Drummond Group’s Electronic Health Records Office of the National Coordinator Authorized Testing and Certification Body program. Shares closed up 0.54 percent on the day at $69.37.

Don’t Miss: Vivus APPLAUDED! FDA Approves Second Diet Drug in a Month.

Kraft Foods Inc. (NYSE:KFT) and SodaStream International (NASDAQ:SODA) have reported an expansion of their strategic partnership for the production, marketing, distribution and sale of the former’s beverage brands for use with the SodaStream soda making system. Initial Kool-Aid flavors will be Cherry, Grape and Tropical Punch, which complement the current co-branded portfolio, that includes varieties of Crystal Light, the top powdered drink mix; and Country Time, the number-one domestic lemonade flavor brand. Financials of the agreement were not divulged. Shares closed up 0.43 percent on the day at 39.97, having traded in a 52-week range of $31.88 to $39.99.

Novavax, Inc. (NASDAQ:NVAX) reports that it has formed a clinical development partnership with PATH to develop its respiratory syncytial virus vaccine for the protection of infants through maternal immunization in low-resource countries. The firm has been awarded around $2 million by PATH for initial funding through the partnership, in partial support a Phase II dose-ranging clinical evaluation in women of childbearing age, which is scheduled for the second half of 2012. Subsequent to this initial study, PATH may choose to remain partners with Novavax, and to supply support for the external clinical development costs via commercialization for this indication. Shares closed up 0.47 percent on the day at $2.14, and have traded in a 52-week range of $1.12 to $2.15.

Deltek, Inc. (NASDAQ:PROJ) has recruited a bank to advise it on selling itself, according to the Wall Street Journal. Shares closed up 8.2 percent on the day at $13.33.

Susquehanna Bancshares, Inc.’s (NASDAQ:SUSQ) dividend is payable to July 31st shareholders of record, on August 20. Shares closed down 0.93 percent on the day at $10.70, and have been traded in a 52-week range of $5.20 to $10.87.

Don’t Miss: Google is Making a HUGE Leap Into Broadband.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business